Blood Peptidome-Degradome Profile of Breast Cancer
Yufeng Shen(Columbia University Irving Medical Center), Richard Smith(Salisbury NHS Foundation Trust), Ronald Moore(Pacific Northwest National Laboratory), Tao Liu(United States Air Force), Nikola Tolić(Environmental Molecular Sciences Laboratory), Francisco J. Esteva(Northwell Health), Rui Zhao(Kunming Medical University), Brianne Petritis(Pacific Northwest National Laboratory), David Camp(Pacific Northwest National Laboratory), Samuel Purvine(Pacific Northwest National Laboratory)
Cited by 59
Related Papers
Genomic responses in mouse models poorly mimic human inflammatory diseases
|Proceedings of the National Academy of Sciences|2013|3k
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
|Cancer Cell|2004|1.9k
The support of human genetic evidence for approved drug indications
|Nature Genetics|2015|1.8k
The Genome of the Sea Urchin <i>Strongylocentrotus purpuratus</i>
|Science|2006|1.2k